Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine sedation for awake fibreoptic bronchoscopy
ACTRN12608000304336Phase 3Terminated
- Sponsor
- Keat Lee
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of dexmedetomidine, sponsored by Keat Lee. Primary endpoint: Hemodynamic changes from baseline. Started Dec 2008; status: terminated.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ACTRN12608000304336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12608000304336.